HIGHLIGHTS
- who: Caterina Conte from the University of Parma, Italy have published the paper: Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors, in the Journal: (JOURNAL)
- what: The latter has emerged as an important biomarker and a priority research focus, being an independent risk factor for metabolic dysfunction, hip fractures, disability, hospitalization, mortality, and poor outcomes in severe illness and surgery . The aim of this study was to assess the relationship between myosteatosis detected during acute COVID-19 and patient reported outcomes at 6 months after discharge.
- how: The study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.